Psoriatic Arthritis

Psoriatic arthritis and gout often present with similar symptoms and radiological signs, an overlap that may be more significant when these diseases occur concomitantly, noted a presenter at the 2020 Congress of Clinical Rheumatology-West.

TNF inhibitors and methotrexate produced similar reductions in HbA1c among patients with psoriatic arthritis, rheumatoid arthritis or ankylosing spondylitis who also have diabetes, according to data published in BMC Rheumatology.

Treatment of psoriatic conditions or Crohn’s disease with ustekinumab was associated with severe cardiovascular events in certain high-risk patients, according to a study.

The Health Assessment Questionnaire-Disability Index and the Patient-Reported Outcomes Measurement Information System-Physical Function had excellent agreement in finding psoriatic arthritis minimal disease activity, according to findings.

The FDA has approved Simponi Aria for the treatment of polyarticular juvenile idiopathic arthritis in patients aged 2 years and older, while also expanding its psoriatic arthritis indication for this patient population, according to a press release from Janssen.

COVID-19 outcomes are worse among patients with inflammatory arthritis receiving glucocorticoids, but not in those receiving anticytokine therapy, according to data published in Arthritis & Rheumatology.

There is much to look forward to in the management of psoriatic arthritis, according to a presenter at the 2020 Congress of Clinical Rheumatology-East.

This episode investigates the history of how psoriatic arthritis became recognized as a distinct disease. Then explores the bone changes and radiographic findings of PsA.

Ixekizumab demonstrated significantly greater joint and skin improvement, through week 52, than adalimumab among patients with psoriatic arthritis, according to data published in the Annals of the Rheumatic Diseases.

Patients with psoriatic arthritis have much to be hopeful about, with understanding of the disease increasing and an expanded range of treatment options available, according to a presenter at the 2020 Rheumatology Nurses Society Annual Conference.